Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 100

Sort by

Sort Order Select

Journal Articles

Correction of ineffective erythropoiesis and durable clinical benefit with exagamglogene autotemcel for transfusion-dependent β-thalassemia

Blood (2025) 146 (Supplement 1): 6089.

https://doi.org/10.1182/blood-2025-6089

Published: 2025

Journal Articles

Sickle cell disease in europe: A cross-border real-world data analysis from the radeep registry

Blood (2025) 146 (Supplement 1): 179.

https://doi.org/10.1182/blood-2025-179

Published: 2025

Journal Articles

The international diamond blackfan anemia syndrome cancer consortium: Preliminary results

Adrianna Vlachos, Marije Bartels, Polyxeni Delaporta, Paola Quarello, Maryam Hussain, Eva Atsidaftos, Katie Mills, Dagmar Pospisilova, Jana Volejnikova, Alexander Puzik, Kruti Revagar, Deena Iskander, Thierry Leblanc, Jason Farrar, Antonis Kattamis, Jeffrey Michael Lipton

Blood (2025) 146 (Supplement 1): 4996.

https://doi.org/10.1182/blood-2025-4996

Published: 2025

Journal Articles

Revisiting erythroid response in the phase 3 BELIEVE trial of luspatercept in patients with transfusion-dependent β-thalassemia using real-world criteria

Khaled Musallam, Maria Domenica Cappellini, Antonis Kattamis, Kevin Kuo, Sujit Sheth, Patricia Martin-Regueira, Loyse Felber Medlin, George Zhang, Christopher Westcott, Ali Taher

Blood (2025) 146 (Supplement 1): 1139.

https://doi.org/10.1182/blood-2025-1139

Published: 2025

Journal Articles

Assessment of the angiogenic proteins placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt-1) in patients with hereditary spherocytosis

Vasiliki Chouliara, Aimilia Mantzou, Polyxeni Delaporta, Stavros Glentis, Evangelos Premetis, Elena Chatzikalil, Konstantinos Bistas, Panagiota Perari, Efthalia-Faidra Agiomavriti-Stephanopoulou, Vasiliki Maravgaki, Sofirela Berdalli, Dimitra Kyriakopoulou, Ioannis Papassotiriou, Antonis Kattamis

Blood (2025) 146 (Supplement 1): 1107.

https://doi.org/10.1182/blood-2025-1107

Published: 2025

Journal Articles

Low hematologic event-free survival with age in shwachman-diamond syndrome

Blood (2025) 146 (Supplement 1): 748.

https://doi.org/10.1182/blood-2025-748

Published: 2025

Journal Articles

First results of exagamglogene autotemcel in pediatric patients aged 5-11 years with transfusion-dependent β-thalassemia or sickle cell disease with recurrent severe vaso-occlusive crises

Blood (2025) 146 (Supplement 1): 379.

https://doi.org/10.1182/blood-2025-379

Published: 2025

Journal Articles

Efficacy of mitapivat in patients with transfusion-dependent alpha-thalassemia: Subgroup analysis from the ENERGIZE-T trial

Blood (2025) 146 (Supplement 1): 4699.

https://doi.org/10.1182/blood-2025-4699

Published: 2025

Journal Articles

Thalassemia in europe: A cross-border real-world data analysis from the radeep registry

Blood (2025) 146 (Supplement 1): 4696.

https://doi.org/10.1182/blood-2025-4696

Published: 2025

Journal Articles

Impact of long-term luspatercept treatment on iron parameters in patients with transfusion-dependent and non-transfusion-dependent β-thalassemia: Results from the phase 3b long-term follow-up study

Ali Taher, Khaled Musallam, Maria Domenica Cappellini, Maria Dimopoulou, Antonis Kattamis, Silverio Perrotta, Paolo Ricchi, Manuela Balocco, Patricia Martin-Regueira, Loyse Felber Medlin, George Zhang, Veronika Pozharskaya, John Porter

Blood (2025) 146 (Supplement 1): 4695.

https://doi.org/10.1182/blood-2025-4695

Published: 2025

Journal Articles

A phase 2 study of luspatercept in adults and adolescents with α-thalassemia: Findings from the dose-confirmation cohort in adolescents

Yongrong Lai, Meng-Yao Lu, Ying Zhao, Antonis Kattamis, Gian Luca Forni, Kitty Formentin, Pablo Gurman, Mingzhao Gao, Loyse Felber Medlin, Patricia Martin-Regueira, Vincent Jaquet, Vip Viprakasit

Blood (2025) 146 (Supplement 1): 4689.

https://doi.org/10.1182/blood-2025-4689

Published: 2025

Journal Articles

The ‘αO2-PRBCThal’ trial on the use of hemanext One® for blood transfusion support transfusion-dependent thalassemia

Polyxeni Delaporta, Efthalia-Faidra Agiomavriti-Stephanopoulou, Elena Chatzikalil, Maria Sykioti, Sofia Giatsiatsiou, Konstantinos Stamoulis, Alkmini Anastasiadi, Vasileios Dendrinos, Pagona Flevari, Vasileios Tzounakas, Anastasios Kriebardis, Sofia Ioannidou, Maria Dimopoulou, Antonis Kattamis

Blood (2025) 146 (Supplement 1): 8224.

https://doi.org/10.1182/blood-2025-8224

Published: 2025

Journal Articles

Oral glucose tolerance test remains the gold standard for diagnosis of glucose metabolism disturbances in thalassemia patients

Polyxeni Delaporta, Konstantinos Bistas, Elena Chatzikalil, Vasiliki Maravgaki, Efthalia-Faidra Agiomavriti-Stephanopoulou, Vasiliki Chouliara, Dimitra Kyriakopoulou, Sofirela Berdalli, Antonis Kattamis

Blood (2025) 146 (Supplement 1): 1144.

https://doi.org/10.1182/blood-2025-1144

Published: 2025

Journal Articles

Abrupt Increases in Ferritin Levels May Indicate a Malignant Process and Not Changes in Iron Overload in Thalassemic Patients

Polyxeni Delaporta, Elena Chatzikalil, Dimitra Kyriakopoulou, Sofirela Berdalli, Vasiliki Chouliara, Maria-Ioanna Hatzieleftheriou, Stavroula Mylona, Antonis Kattamis

Blood (2024) 144 (Supplement 1): 3860.

https://doi.org/10.1182/blood-2024-206111

Published: 2024

Journal Articles

Efficacy and Safety of Combination Therapy with Oral Iron Chelators Deferiprone and Deferasirox in Patients with β-Thalassemia Major: A Systematic Literature Review

Janet L. Kwiatkowski, Sujit Sheth, Antonis Kattamis, Francesco Bianchi, Fernando Tricta, Caroline Fradette, Roberta Luzzi, Antonio Piga

Blood (2024) 144 (Supplement 1): 5268.

https://doi.org/10.1182/blood-2024-207562

Published: 2024

Journal Articles

Durable Clinical Benefits with Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

Blood (2024) 144 (Supplement 1): 512.

https://doi.org/10.1182/blood-2024-205779

Published: 2024

Journal Articles

ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia

Blood (2024) 144 (Supplement 1): 409.

https://doi.org/10.1182/blood-2024-200867

Published: 2024

Journal Articles

Incidence of Myeloid Malignancy in Shwachman-Diamond Syndrome: An International Cohort Study

Blood (2024) 144 (Supplement 1): 2703.

https://doi.org/10.1182/blood-2024-206661

Published: 2024

Journal Articles

Infants with KMT2A-Rearranged Acute Lymphoblastic Leukemia Do Benefit from the Addition of Blinatumomab to Backbone Treatment Protocols

Georgia Avgerinou, Maria Fillipidou, Ilona Binenbaum, Stavros Glentis, Katerina Kaisari, Eugene Goussetis, Anna Komitopoulou, Foteini Perganti, Stefanos I. Papadhimitriou, Marianna Tzanoudaki, Antonis Kattamis

Blood (2024) 144 (Supplement 1): 5886.

https://doi.org/10.1182/blood-2024-206817

Published: 2024

Journal Articles

Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy

Blood (2024) 144 (15): 1633–1645.

https://doi.org/10.1182/blood.2023023349

Published: 2024

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Correction of ineffective erythropoiesis and durable clinical benefit with exagamglogene autotemcel for transfusion-dependent β-thalassemia

Sickle cell disease in europe: A cross-border real-world data analysis from the radeep registry

The international diamond blackfan anemia syndrome cancer consortium: Preliminary results

Revisiting erythroid response in the phase 3 BELIEVE trial of luspatercept in patients with transfusion-dependent β-thalassemia using real-world criteria

Assessment of the angiogenic proteins placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt-1) in patients with hereditary spherocytosis

Low hematologic event-free survival with age in shwachman-diamond syndrome

First results of exagamglogene autotemcel in pediatric patients aged 5-11 years with transfusion-dependent β-thalassemia or sickle cell disease with recurrent severe vaso-occlusive crises

Efficacy of mitapivat in patients with transfusion-dependent alpha-thalassemia: Subgroup analysis from the ENERGIZE-T trial

Thalassemia in europe: A cross-border real-world data analysis from the radeep registry

Impact of long-term luspatercept treatment on iron parameters in patients with transfusion-dependent and non-transfusion-dependent β-thalassemia: Results from the phase 3b long-term follow-up study

A phase 2 study of luspatercept in adults and adolescents with α-thalassemia: Findings from the dose-confirmation cohort in adolescents

The ‘αO2-PRBCThal’ trial on the use of hemanext One® for blood transfusion support transfusion-dependent thalassemia

Oral glucose tolerance test remains the gold standard for diagnosis of glucose metabolism disturbances in thalassemia patients

Abrupt Increases in Ferritin Levels May Indicate a Malignant Process and Not Changes in Iron Overload in Thalassemic Patients

Efficacy and Safety of Combination Therapy with Oral Iron Chelators Deferiprone and Deferasirox in Patients with β-Thalassemia Major: A Systematic Literature Review

Durable Clinical Benefits with Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia

Incidence of Myeloid Malignancy in Shwachman-Diamond Syndrome: An International Cohort Study

Infants with KMT2A-Rearranged Acute Lymphoblastic Leukemia Do Benefit from the Addition of Blinatumomab to Backbone Treatment Protocols

Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only